Washington Capital Management’s Quest Diagnostics DGX Stock Holding History

Washington Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$377K	Hold	1,780	–	–	0.25%	99
2026 Q1	$349K	Hold	1,780	–	–	0.29%	91
2025 Q4	$309K	Sell	1,780 -25	-1%	-$4.55K	0.25%	90
2025 Q3	$344K	Sell	1,805 -150	-8%	-$26.6K	0.25%	101
2025 Q2	$351K	Sell	1,955 -2,550	-57%	-$443K	0.26%	100
2025 Q1	$762K	Hold	4,505	–	–	0.61%	39
2024 Q4	$680K	Hold	4,505	–	–	0.54%	44
2024 Q3	$699K	Hold	4,505	–	–	0.54%	47
2024 Q2	$617K	Hold	4,505	–	–	0.52%	52
2024 Q1	$600K	Buy	+4,505	New	+$585K	0.49%	62
2022 Q1	–	Sell	-6,565	Closed	-$1.14M	–	108
2021 Q4	$1.14M	Sell	6,565 -140	-2%	-$21.3K	0.92%	31
2021 Q3	$974K	Sell	6,705 -150	-2%	-$21.9K	0.86%	33
2021 Q2	$905K	Hold	6,855	–	–	1.1%	31
2021 Q1	$880K	Hold	6,855	–	–	0.82%	31
2020 Q4	$817K	Hold	6,855	–	–	0.78%	31
2020 Q3	$785K	Hold	6,855	–	–	0.81%	29
2020 Q2	$781K	Sell	6,855 -1,515	-18%	-$161K	0.87%	29
2020 Q1	$672K	Buy	+8,370	New	+$867K	0.85%	29

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SIC

Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Washington Capital Management's DGX Position: Q2 2026 in Review

Washington Capital Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,780 shares worth $377K. The position accounts for 0.25% of the portfolio, ranked #99.

Washington Capital Management first reported a position in DGX in Q1 2020 and has held it in 18 quarters since. The position peaked at $1.14M in Q4 2021. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Washington Capital Management held 1,780 shares of Quest Diagnostics worth $377K as of Q2 2026.
Washington Capital Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.25% of Washington Capital Management's portfolio in Q2 2026, its #99 holding.
Washington Capital Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 18 quarters since.
Washington Capital Management's Quest Diagnostics position peaked at $1.14M in Q4 2021.
380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Washington Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.